Your LATAM CRO for High-Impact,
High-Integrity Research.
High-Integrity Research.
Quick Facts
Years of experience
0
Trials conducted
0
Patients enrolled
0
Regional Reach & Operational Strength
Presence in major LATAM countries
Argentina
Brasil
México
Chile
Colombia
Uruguay
Bolivia
Fast-track regulatory approvals (2–3 months) and country start-up (average 5 months)
Proven relationships with top-performing sites (public, private, academic)
Proven relationships with patient organizations focusing on rare diseases
Procedures fully audited and certified, guaranteeing regulatory compliance, patient safety, and data integrity
Translational & Early-Phase Excellence
Our specialized unit in Translational Medicine and Clinical Development supports early-phase trials with:
- Preclinical-to-clinical transition planning
- First-in-Human and Phase I execution
- Biomarker-driven study design
- Adaptive trial methodologies
- Regulatory pathway consultation for rare and orphan indications
This capability allows LAT Research to support high-science programs from discovery to proof-of-concept
Be part of our Networking
Want to see what our team can make possible?
Connect with us!
Request for Proposal
Ready to work with a CRO partner who gives you our full attention?